Genetic reasons behind Raynaud’s phenomenon discovered

FHS
August 4, 2023
11:56 am

Researchers at Queen Mary University of London’s Precision Healthcare Research Institute (PHURI) and the Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin have identified the genetic causes of Raynaud’s phenomenon.

FDA approves Madrigal’s NASH drug, marking the first-ever treatment for the liver disease

Madrigal Pharmaceuticals’ NASH drug won an accelerated approval on Thursday, becoming the first treatment for a liver disease that for years has vexed scientists and

March 15, 2024

Reduced-Dose Schedule of Cabazitaxel Viable for Seniors With mCRPC

A reduced-dose schedule of cabazitaxel (Jevtana) plus prophylactic granulocyte colony-stimulating factor (G-CSF) should be offered to older men with metastatic castration-resistant prostate cancer (mCRPC), according

November 2, 2023

Younger Adults Are Going Public With Their Digestive Problems

Lauren Bell was stressed out and just starting her first job post-college in New York City when she realized a bout of food poisoning wasn’t

August 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.